bacterial pneumonia
Information
- Disease name
- bacterial pneumonia
- Disease ID
- DOID:874
- Description
- "A pneumonia involving inflammation of the lungs caused by bacteria." [url:http\://en.wikipedia.org/wiki/Bacterial_pneumonia]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04779242 | Active, not recruiting | Phase 3 | Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia | February 25, 2021 | April 2024 |
| NCT00080496 | Completed | Phase 3 | Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia | July 2003 | December 2006 |
| NCT00081575 | Completed | Phase 3 | Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia | January 2004 | March 2005 |
| NCT00107952 | Completed | Phase 3 | Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus | February 2005 | July 2007 |
| NCT00124020 | Completed | Phase 3 | Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus | January 2005 | May 2007 |
| NCT00451386 | Completed | Phase 2 | Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036) | January 2002 | December 2003 |
| NCT00502801 | Completed | Phase 2 | An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia | August 2007 | November 2008 |
| NCT00509106 | Completed | Phase 3 | Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia | July 2007 | June 2009 |
| NCT00621504 | Completed | Phase 3 | Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia | January 2008 | June 2009 |
| NCT00079885 | Completed | Phase 3 | Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia | November 2003 | July 2005 |
| NCT00763620 | Completed | N/A | Assessment of the Diagnostic Capacity of the Mini-broncho Alveolar Lavage Performed Through a Suction Catheter | February 2009 | June 2011 |
| NCT00877422 | Completed | N/A | Vitamin D Supplementation Prevents Elderly Pneumonia | August 2008 | |
| NCT05417997 | Completed | Phase 3 | Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients | May 29, 2021 | December 2, 2021 |
| NCT01868113 | Completed | Phase 3 | Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial | December 2012 | January 2014 |
| NCT02493764 | Completed | Phase 3 | Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) | November 24, 2015 | April 3, 2019 |
| NCT02531438 | Completed | Phase 3 | Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13) | November 2015 | March 10, 2017 |
| NCT03158727 | Completed | Phase 1/Phase 2 | Cx611-0204 SEPCELL Study | January 30, 2017 | July 7, 2020 |
| NCT05629741 | Recruiting | Phase 1 | A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 | November 14, 2022 | May 11, 2024 |
| NCT05531149 | Recruiting | Phase 3 | Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia | December 22, 2022 | August 31, 2025 |
| NCT01570192 | Terminated | Phase 2 | Clinical Trials to Reduce the Risk of Antimicrobial Resistance | September 2010 | April 2015 |
| NCT03862040 | Terminated | Phase 1 | Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia | February 20, 2019 | October 15, 2019 |
| NCT03752320 | Unknown status | Multiplex Polymerase Chain Reaction in Postoperative Pneumonia After Thoracic Surgery | February 7, 2019 | February 2020 | |
| NCT04952337 | Unknown status | Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ) | October 1, 2020 | July 1, 2022 | |
| NCT00645619 | Withdrawn | Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children | March 24, 2008 | March 26, 2008 |
- Disase is a (Disease Ontology)
- DOID:552
- Cross Reference ID (Disease Ontology)
- ICD10CM:J15.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:482.9
- Cross Reference ID (Disease Ontology)
- MESH:D018410
- Cross Reference ID (Disease Ontology)
- NCI:C26704
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:53084003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0004626
- Exact Synonym (Disease Ontology)
- gram-negative pneumonia
- Exact Synonym (Disease Ontology)
- Pneumonia due to other gram-negative bacteria